Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
4.040
-0.340 (-7.76%)
Jan 22, 2026, 4:00 PM EST - Market closed

CPIX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
603327336944
Upgrade
Market Cap Growth
87.65%24.62%-17.94%-52.77%55.54%-43.35%
Upgrade
Enterprise Value
553727315937
Upgrade
Last Close Price
4.042.371.792.254.672.95
Upgrade
Forward PE
-24.0024.0024.0024.00-
Upgrade
PS Ratio
1.440.880.680.781.921.18
Upgrade
PB Ratio
2.311.480.910.911.620.95
Upgrade
P/TBV Ratio
5.938.394.396.843.832.46
Upgrade
P/FCF Ratio
8.97-4.593.9011.048.40
Upgrade
P/OCF Ratio
8.84-4.383.8510.868.18
Upgrade
PEG Ratio
-1.521.521.521.521.52
Upgrade
EV/Sales Ratio
1.340.980.670.731.650.99
Upgrade
EV/EBITDA Ratio
41.49-----
Upgrade
EV/FCF Ratio
8.24-4.563.679.496.99
Upgrade
Debt / Equity Ratio
0.400.910.630.580.380.36
Upgrade
Debt / EBITDA Ratio
3.1750.3932.1015.97--
Upgrade
Debt / FCF Ratio
1.52-3.172.512.573.24
Upgrade
Asset Turnover
0.580.480.450.470.400.37
Upgrade
Inventory Turnover
1.721.530.841.000.920.89
Upgrade
Quick Ratio
1.050.941.001.151.761.45
Upgrade
Current Ratio
1.231.151.281.612.371.95
Upgrade
Return on Equity (ROE)
-13.28%-24.88%-19.41%-14.38%-12.51%-13.53%
Upgrade
Return on Assets (ROA)
-2.86%-5.11%-4.44%-4.02%-5.30%-3.97%
Upgrade
Return on Invested Capital (ROIC)
-15.26%-23.60%-18.67%-16.59%-21.68%-15.27%
Upgrade
Return on Capital Employed (ROCE)
-7.80%-14.60%-11.50%-8.90%-11.80%-9.00%
Upgrade
Earnings Yield
-5.51%-19.47%-23.51%-17.12%-5.09%-7.54%
Upgrade
FCF Yield
11.14%-2.04%21.77%25.66%9.05%11.91%
Upgrade
Buyback Yield / Dilution
-4.26%1.67%1.82%2.29%1.70%1.52%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q